SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated (SBC) Market Cap

SBC Medical Group Holdings Incorporated has a market capitalization of $374.4M.

Financials based on reported quarter end 2025-12-31

Price: $3.65

โ–ผ -0.07 (-1.88%)

Market Cap: 374.41M

NASDAQ ยท time unavailable

CEO: Yoshiyuki Aikawa

Sector: Industrials

Industry: Consulting Services

IPO Date: 2022-09-26

Website: https://sbc-holdings.com

SBC Medical Group Holdings Incorporated (SBC) - Company Information

Market Cap: 374.41M ยท Sector: Industrials

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.

Analyst Sentiment

83%
Strong Buy

Based on 1 ratings

Analyst 1Y Forecast: $9.00

Average target (based on 2 sources)

Consensus Price Target

Low

$9

Median

$9

High

$9

Average

$9

Potential Upside: 146.6%

Price & Moving Averages

Loading chart...

Fundamentals Overview

Loading fundamentals overview...

๐Ÿ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"SBC reported revenue of $39.6M and net income of $14.2M (EPS: $0.14) for the period ended 2025-12-31, translating to a net margin of ~35.9%. Free cash flow was $65.3M, supported by operating cash flow of $66.2M, with minimal capex of $0.9M. Balance sheet strength is highlighted by net debt of -$112.1M (net cash), with total assets of $380.4M and total equity of $263.3M versus liabilities of $117.1M. Profitability appears strong given the high net margin and positive earnings, while the cash flow profile suggests earnings are converting well into cash. Liquidity risk looks limited with net cash and substantial equity, and the company is not showing cash strain from heavy reinvestment needs (capex is low relative to operating cash flow). The absence of dividends means shareholder returns are likely driven primarily by capital gains rather than income. On valuation and sentiment, the provided consensus price target is $9, implying upside relative to the current price of $4.09 (context: 24.7% 1-year gain). That positive momentum supports the shareholder return view, though specific valuation multiples (P/E, FCF yield) were not supplied."

Revenue Growth

Fair

Revenue is provided at $39.6M, but no prior-period revenue is included, so growth rate and durability cannot be assessed from this dataset.

Profitability

Strong

Net income of $14.2M implies an ~35.9% net margin, indicating strong profitability relative to revenue. EPS is positive at $0.14.

Cash Flow Quality

Strong

Operating cash flow of $66.2M converts to free cash flow of $65.3M, with only $0.9M capex. Dividends are $0, but cash generation is solid.

Leverage & Balance Sheet

Strong

Net debt is -$112.1M (net cash), with equity of $263.3M versus liabilities of $117.1M, suggesting strong financial resilience.

Shareholder Returns

Positive

Total shareholder value appears driven mainly by price performance: +24.7% over 1 year. Dividends are not paid and buybacks are not provided, so income/repurchase contribution is unknown.

Analyst Sentiment & Valuation

Neutral

Consensus target is $9 versus a current price of $4.09 (with 1-year momentum positive). However, key valuation multiples (P/E, FCF yield) are not provided, limiting precision.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
ยฉ 2026 Stock Market Info โ€” SBC Medical Group Holdings Incorporated (SBC) Financial Profile